Zhou Y - Search Results

1

Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma.

Li A, Yan Q, Zhao X, Zhong J, Yang H, Feng Z, Du Y, Wang Y, Wang Z, Wang H, Zhou Y, Liu S, Nie Y. Li A, et al. Among authors: zhou y. Oncotarget. 2016 Jan 5;7(1):524-37. doi: 10.18632/oncotarget.6358. Oncotarget. 2016. PMID: 26594798 Free PMC article.

2

[Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment].

Li YY, Nie YQ, Xie J, Tan HZ, Zhou YJ, Wang H. Li YY, et al. Zhonghua Nei Ke Za Zhi. 2006 Jul;45(7):552-5. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17074108 Clinical Trial. Chinese.

3

[Association of nonalcoholic fatty liver disease with serum adiponectin and insulin resistance].

Shi SL, Nie YQ, Li YY, Zhou YJ, Ma JX. Shi SL, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 Jan;15(1):58-9. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17244464 Chinese. No abstract available.

4

[The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease].

Yang H, Li YY, Nie YQ, Zhou YJ, DU YL, Sha WH, Hong Y. Yang H, et al. Among authors: zhou yj. Zhonghua Gan Zang Bing Za Zhi. 2007 Jul;15(7):525-8. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17669243 Chinese.

5

Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.

Li YY, Sha WH, Zhou YJ, Nie YQ. Li YY, et al. J Gastroenterol Hepatol. 2007 Dec;22(12):2148-54. doi: 10.1111/j.1440-1746.2006.04719.x. J Gastroenterol Hepatol. 2007. PMID: 18031373 Clinical Trial.

6

Prevalence of fatty liver disease and its risk factors in the population of South China.

Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ. Zhou YJ, et al. World J Gastroenterol. 2007 Dec 21;13(47):6419-24. doi: 10.3748/wjg.v13.i47.6419. World J Gastroenterol. 2007. PMID: 18081233 Free PMC article.

7

[Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].

Zhan Q, Li YY, Nie YQ, Zhou YJ, DU YL, Sha WH, Wang H. Zhan Q, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 May;16(5):375-8. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18510853 Chinese.

8

Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people.

Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, Shi SL, Lai XB, Huang HL. Zhou YJ, et al. J Gastroenterol Hepatol. 2010 Apr;25(4):772-7. doi: 10.1111/j.1440-1746.2009.06144.x. J Gastroenterol Hepatol. 2010. PMID: 20492333

9

The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.

Cao CY, Li YY, Zhou YJ, Nie YQ, Wan YJ. Cao CY, et al. Tohoku J Exp Med. 2012 Aug;227(4):253-62. doi: 10.1620/tjem.227.253. Tohoku J Exp Med. 2012. PMID: 22820754 Free PMC article.

10

The effect of miRNA-122 in regulating fat deposition in a cell line model.

Nie YQ, Cao J, Zhou YJ, Liang X, Du YL, Wan YJ, Li YY. Nie YQ, et al. J Cell Biochem. 2014 May;115(5):839-46. doi: 10.1002/jcb.24725. J Cell Biochem. 2014. PMID: 24288170 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71,594 results

Search Page

Filters